2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions

View by Date

Tuesday, September 24, 2019

1:45pm-3:15pm: Characteristic Parkinsonism Questionnaire for the Discrimination of Parkinson’s Disease Dementia from Vascular Dementia

PY. Chiu (Changhua, Taiwan)

Rating Scales · Les Muses Terrace, Level 3

1:45pm-3:15pm: Characteristics and correlative factors of autonomic dysfunction in Chinese Parkinson’s disease

Z. Zhou, LP. Zhu, XT. Zhou, XX. Zhou, YW. Zhao, LX. Qin, Y. Yang, LJ. Fang, Y. Tian, ZQ. Wang, QY. Sun, Q. Xu, JC. Li, JF. Guo, XX. Yan, BS. Tang (Changsha, China)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: Characteristics and outcome of patients with Parkinson’s disease admitted to intensive care unit

O. Benhadj Salem, S. Demeret, A. Demoule, F. Bolgert, H. Outin, T. Sharshar, D. Grabli (Paris, France)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: Characteristics of African American Parkinson’s Disease patients seen in a Large Clinic Practice

M. Dean, M. Patel, K. Barnes, D. Standaert (Birmingham, AL, USA)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: Characteristics of arm tremors in primary orthostatic tremor

J. Tashiro, H. Ohtsuka, M. Hirotani, Y. Iida, S. Hamada, H. Soma, M. Nonaka, S. Honma, A. Takei, F. Moriwaka, K. Tashiro (Sapporo, Japan)

Tremor · Les Muses Terrace, Level 3

1:45pm-3:15pm: Characteristics of gait and quality of life in Parkinson’s disease

JW. Kim, SM. Cheon (Busan, Republic of Korea)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: Characteristics of patients with essential tremor evaluated for deep brain stimulation surgery at a tertiary center

L. Deuel, J. Feuerstein, B. Berman, B. Hoyt, D. Kern (Aurora, CO, USA)

Tremor · Les Muses Terrace, Level 3

1:45pm-3:15pm: Characterization of the motor phenotype and striatal muscle analysis in a mouse model of hereditary spasticity

A. Vignaud, C. Rivares, W. Noort, B. Koopmans, M. Loos, RT. Jaspers, M. Kalinichev (Les Ulis, France)

Spasticity · Les Muses Terrace, Level 3

1:45pm-3:15pm: CHCHD2 maintains the MICOS and inhibits PINK1/Parkin mediated mitophagy in an experimental model of Parkinson’s disease

X. Chen, M. Zhou, XQ. Zhu, SX. Huang, WY. Guo, Z. Pei, PY. Xu (Guangzhou, China)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3

1:45pm-3:15pm: Cholecalciferol (VD3) attenuated motor deficits and dyskinesia in Hemi-Parkinsonian mice: behavioural, biochemical & electrophysiological implications

A. Bayo-Olugbami, A. Oyewole, A. Nafiu, A. Amin, B. Ogundele, B. Owoyele, C. Lee (Ilorin, Nigeria)

Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3